Is Oklo Stock a Buy Now?
Key Points
Oklo recently acquired radioisotope company Atomic Alchemy in a $25 million all-stock deal.
It's awaiting approval from the Nuclear Regulatory Commission for a commercial operating license.
The company also signed a deal with Meta Platforms to support its data centers.
Last year, Oklo (NYSE: OKLO) had one of the more volatile runs of any stock. At one point, Oklo surged more than 230% before abruptly declining from its peak. Now, shares are well below their all-time high of $193. As of March 26, the stock is trading around $52 per share.
Investors who witnessed this whiplash are asking whether the nuclear company is worth buying now. So, is it?
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Closing in on commercial viability
Oklo is diversifying its business beyond just small modular reactors (SMRs). First, the company acquired Atomic Alchemy in a $25 million stock deal. Atomic Alchemy was just granted a license from the U.S. Nuclear Regulatory Commission (NRC) for isotope material. This acquisition will bolster Oklo's capabilities in nuclear fuel recycling and radioisotope production.
Image source: Getty Images.
Oklo has also recently signed partnerships with Newcleo and, most notably, Meta Platforms. The deal with Meta is to develop a 1.2 gigawatt (GW) campus in Ohio to support Meta's regional data centers. The agreement allows for Meta to prepay for power and provide funding to advance project certainty for Oklo's Aurora powerhouse deployment, according to an Oklo press release. This marks Oklo's first major commercial deal.
The company is also working with the U.S. Department of Energy to demonstrate its technology through a new Reactor Pilot Program. If successful, this could move Oklo closer to securing the licensing needed to move into commercial production.
The Oklo rollercoaster continues
The stock remains extraordinarily speculative and doesn't move based on fundamentals because Oklo is still considered pre-revenue. The enthusiasm for Oklo's technology and future demand sent it skyrocketing last year, but concerns over high capital expenditures and rising costs sent it spiraling back down. Oklo's daily market movements are not appropriate for risk-averse investors.
Oklo's shares are currently trading below the average analyst price target of $97 as well. Oklo's financials reflect that it hasn't yet moved into commercial production. The company's latest report showed that total operating expenses for 2025 reached $139 million, up from $52 million the year prior.
Should you buy Oklo?
The company's future hinges upon acquiring an NRC commercial operating license. Until then, everything about Oklo will remain speculative. Should the NRC grant the license in 2026 and Oklo can execute on its commitments, the stock should see a significant shift upward.
The bear case for Oklo directly contradicts the paragraph above. A failure to gain an NRC license means no revenue and more cash burn. This would be catastrophic for the stock.
All told, this is an exciting company that's nearing an inflection point. Oklo stands at the crossroads of the next generation of nuclear energy and immense power demand from artificial intelligence. Even in the most bullish case, profitability won't happen overnight, though. Optimistic investors should still have a high risk tolerance and a longer time horizon.
Should you buy stock in Oklo right now?
Before you buy stock in Oklo, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oklo wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $503,861!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,026,987!*
Now, it’s worth noting Stock Advisor’s total average return is 884% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 30, 2026.
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Meta Platforms. The Motley Fool has a disclosure policy.
